VESOXX

Active ingredient: Oxybutynin Hydrochloride
Presentation: Solution For Intravesical
Strength: 1MG/1ML
Pack size: 100 Prefilled Syringes

Vesoxx is indicated for the suppression of neurogenic detrusor overactivity (NDO) in children from 6 years of age and adults, who are managing bladder emptying by clean intermittent catheterization (CIC), if they cannot be adequately managed by oral anticholinergic treatment due to lack of efficacy and/or intolerable side effects.

VESOXX